GSK (LSE: GSK) has settled 93% of Zantac (ranitidine) product liability cases in the USA, agreeing to pay up to $2.2 billion ...

Johnson & Johnson’s Tecvayli (teclistamab) has been recommended by NICE as a first-line treatment for myeloma in England and ...

Insitro has signed three strategic agreements with Eli Lilly aimed at advancing treatments for metabolic diseases like MASLD, ...

US pharma giant Pfizer today released positive top line results from the final prespecified overall survival (OS) analysis of ...

Nanoscope Therapeutics says that, following a productive FDA meeting with the US Food and Drug Administration (FDA) for its ...

The US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for Part 1 of the New Drug Application ...

The European Medicines Agency (EMA) has accepted for review the Marketing Authorization Applications for AVT03, a proposed ...

Yesterday, the US Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), ...

US vaccine company Gritstone bio (Nasdaq: GRTS) has filed for bankruptcy. This follows the presentation of disappointing data ...

China's Quantum Pharmaceuticals has announced a major licensing deal between its subsidiary Ailux Biologics and Johnson & ...

In what Astella Pharma (TYO: 4503) calls “a landmark decision for advanced bladder cancer patients,” the Japanese drugmaker ...

Beijing’s InnoCare Pharma has announced promising Phase II results for its TYK2 inhibitor, ICP-488, in moderate-to-severe ...